IN2013MU03370A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU03370A IN2013MU03370A IN3370MU2013A IN2013MU03370A IN 2013MU03370 A IN2013MU03370 A IN 2013MU03370A IN 3370MU2013 A IN3370MU2013 A IN 3370MU2013A IN 2013MU03370 A IN2013MU03370 A IN 2013MU03370A
- Authority
- IN
- India
- Prior art keywords
- self
- delivery system
- drug delivery
- emulsifying drug
- pharmaceutically acceptable
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 abstract 2
- XPOQHMRABVBWPR-UHFFFAOYSA-N Efavirenz Natural products O1C(=O)NC2=CC=C(Cl)C=C2C1(C(F)(F)F)C#CC1CC1 XPOQHMRABVBWPR-UHFFFAOYSA-N 0.000 abstract 1
- XPOQHMRABVBWPR-ZDUSSCGKSA-N efavirenz Chemical compound C([C@]1(C2=CC(Cl)=CC=C2NC(=O)O1)C(F)(F)F)#CC1CC1 XPOQHMRABVBWPR-ZDUSSCGKSA-N 0.000 abstract 1
- 229960003804 efavirenz Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2014/053142 WO2015059466A1 (en) | 2013-10-25 | 2014-10-22 | Pharmaceutical compositions comprising efavirenz |
| IN3370MU2013 IN2013MU03370A (enrdf_load_stackoverflow) | 2013-10-25 | 2014-10-22 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3370MU2013 IN2013MU03370A (enrdf_load_stackoverflow) | 2013-10-25 | 2014-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU03370A true IN2013MU03370A (enrdf_load_stackoverflow) | 2015-09-25 |
Family
ID=51947382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3370MU2013 IN2013MU03370A (enrdf_load_stackoverflow) | 2013-10-25 | 2014-10-22 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU03370A (enrdf_load_stackoverflow) |
| WO (1) | WO2015059466A1 (enrdf_load_stackoverflow) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3645003A4 (en) | 2017-06-30 | 2021-03-10 | VIIV Healthcare Company | COMBINATION AND USES AND TREATMENTS THEREOF |
| ES2732498B2 (es) * | 2018-05-21 | 2020-04-27 | Consejo Superior Investigacion | Uso de efavirenz para el tratamiento de enfermedades de almacenamiento lipidico. |
| GB202009685D0 (en) * | 2020-06-25 | 2020-08-12 | Viiv Healthcare Co | Formulations |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA72207C2 (uk) | 1998-04-07 | 2005-02-15 | Брістол- Майєрс Сквібб Фарма Компані | Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення |
| PE20000559A1 (es) | 1998-05-27 | 2000-07-05 | Merck & Co Inc | Formulacion de tabletas comprimidas de efavirenz |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| CA2796494A1 (en) | 2010-04-20 | 2011-10-27 | Cipla Limited | Pharmaceutical composition |
-
2014
- 2014-10-22 WO PCT/GB2014/053142 patent/WO2015059466A1/en active Application Filing
- 2014-10-22 IN IN3370MU2013 patent/IN2013MU03370A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015059466A1 (en) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023000320A (es) | Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion. | |
| PH12019501076A1 (en) | Pharmaceutical formulations | |
| EP3710079A4 (en) | SYSTEMS, DEVICES, FORMULATIONS AND PROCEDURES FOR CONTROLLED INGREDIENT DELIVERY | |
| EP3272387A4 (en) | Drug administration device, and manufacturing method for drug administration device | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| EP3664885A4 (en) | TRANSDERMAL DRUG DELIVERY SYSTEM | |
| IN2013MU00711A (enrdf_load_stackoverflow) | ||
| IL273704A (en) | Pharmaceutical bilayer tablet formulations | |
| EP3534987A4 (en) | ADJUSTABLE-DOSE DRUG DELIVERY SYSTEM | |
| IN2013MU01985A (enrdf_load_stackoverflow) | ||
| EA201991265A1 (ru) | Лекарственные формы с отсроченным высвобождением, содержащие диметилфумарат | |
| IN2013MU03370A (enrdf_load_stackoverflow) | ||
| EP3288544A4 (en) | Hypromellose-graft-chitosan and methods thereof for sustained drug delivery | |
| EP3925647A4 (en) | DEVICE FOR ADMINISTRATION OF DRUG SOLUTIONS | |
| IL291479A (en) | Ocular device and drug delivery system, with case | |
| EP3225267A4 (en) | Drug administration mechanism, method for using drug administration mechanism, and pump unit for drug administration mechanism | |
| WO2019059868A3 (en) | PHARMACEUTICAL COMBINATIONS OF TENOFOVIR, EMTRICITABINE AND EFAVIRENZ | |
| PH12018501991A1 (en) | Pharmaceutical composition for use in treating fibrosis | |
| IN2013MU02015A (enrdf_load_stackoverflow) | ||
| ZA202105940B (en) | Drug delivery system | |
| HK40052846B (en) | Drug delivery devices | |
| HK40079956A (en) | Drug delivery device | |
| HK40073756A (en) | Drug delivery device | |
| HK40074171A (en) | Drug delivery device | |
| HK40074172A (en) | Drug delivery device |